AAV-CYP46A1 is beneficial in Alzheimer's disease: from mice to non-human primates

被引：0
|
作者：
Alves, S. [7 ]
Michaelsen-Preusse, K. [6 ]
Audrain, M. [1 ,2 ,3 ]
Aron-Badin, R. [4 ]
Lamaziere, A. [5 ]
Rey, E. [1 ,2 ,3 ]
Fol, R. [1 ,2 ,3 ]
Braudeau, J. [1 ,2 ,3 ]
Despres, G. [5 ]
Fouquet, F. [1 ,2 ,3 ]
Korte, M. [6 ]
Hantraye, P. [4 ]
Aubourg, P. [1 ,2 ,3 ]
Cartier, N. [1 ,2 ,3 ]
机构：
[1] INSERM, U1169, Le Kremlin Bicetre, France
[2] MIRCen CEA, F-91400 Orsay, France
[3] Univ Paris Saclay, Univ Paris Sud, F-91400 Orsay, France
[4] MIRCen, I2BM, DSV, CEA, F-92265 Fontenay Aux Roses, France
[5] Sorbonne Univ, Pierre & Marie Curie Paris6, Lab Mass Spectrometry,CNRS,LBM, INSERM,ERL 1157,UMR 7203, Paris, France
[6] TU Braunschweig, Inst Zool, Div Cellular Neurobiol, Brunswick, ME USA
[7] Brainvectis Therapeut, F-92265 Fontenay Aux Roses, France
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P221
引用
收藏
页码：A77 / A77
页数：1
相关论文
共 50 条
  • [21] Virulence of oral Fusobacterium nucleatum from humans and non-human primates in mice
    Gaetti-Jardim, E
    Luvizotto, MCR
    Avila-Campos, MJ
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2000, 31 (02) : 146 - 150
  • [22] A chemical approach for global protein knockdown from mice to non-human primates
    Xiuyun Sun
    Jun Wang
    Xia Yao
    Wen Zheng
    Yang Mao
    Tianlong Lan
    Liguo Wang
    Yonghui Sun
    Xinyi Zhang
    Qiuye Zhao
    Jianguo Zhao
    Rui-Ping Xiao
    Xiuqin Zhang
    Guangju Ji
    Yu Rao
    Cell Discovery, 5
  • [23] A chemical approach for global protein knockdown from mice to non-human primates
    Sun, Xiuyun
    Wang, Jun
    Yao, Xia
    Zheng, Wen
    Mao, Yang
    Lan, Tianlong
    Wang, Liguo
    Sun, Yonghui
    Zhang, Xinyi
    Zao, Qiuye
    Zhao, Jianguo
    Xiao, Rui-Ping
    Zhang, Xiuqin
    Ji, Guangju
    Rao, Yu
    CELL DISCOVERY, 2019, 5 (1)
  • [24] Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study
    Jester, Hannah M.
    Gosrani, Saahj P.
    Ding, Huiping
    Zhou, Xueyan
    Ko, Mei-Chuan
    Ma, Tao
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 88 (03) : 957 - 970
  • [25] AAV-mediated CYP46A1 gene therapy for Huntington's disease
    Cartier, N.
    Alves, S.
    Christaller, W.
    Subashi, E.
    Kacher, R.
    Lamaziere, A.
    Despres, G.
    Saudou, F.
    Caboche, J.
    Betuing, S.
    HUMAN GENE THERAPY, 2017, 28 (12) : A3 - A3
  • [26] Quantitative Analysis of Subretinal AAV-GFP in Fluorescent Fundoscopy Images from Non-Human Primates
    Newmark, Judith A.
    Timmers, Adrian M.
    Song, Chunjuan
    Lie, Guo-Jie
    Shearman, Mark S.
    MOLECULAR THERAPY, 2018, 26 (05) : 48 - 48
  • [27] Successful repeated hepatic gene delivery in mice and non-human primates achieved by sequential administration of AAV2/5 and AAV1 vector serotypes
    Majowicz, Anna
    Salas, David
    Aseguinolaza, Gloria Gonzalez
    Petry, Harald
    Ferreira, Valerie
    HUMAN GENE THERAPY, 2014, 25 (11) : A53 - A53
  • [28] Shedding light on gene therapy of Parkinson's disease in non-human primates
    Yan, Xunyi
    Jin, Xin
    INNOVATION, 2024, 5 (02):
  • [29] AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice
    Liguore, William A.
    Domire, Jacqueline S.
    Button, Dana
    Wang, Yun
    Dufour, Brett D.
    Srinivasan, Sathya
    McBride, Jodi L.
    MOLECULAR THERAPY, 2019, 27 (11) : 2018 - 2037
  • [30] Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates
    Collier, Timothy J.
    Kanaan, Nicholas M.
    Kordower, Jeffrey H.
    NATURE REVIEWS NEUROSCIENCE, 2011, 12 (06) : 359 - 366
12345